Prot #GS-US-292-0104: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Posit

Project: Research project

Project Details

StatusFinished
Effective start/end date5/15/13 → 8/31/20

Funding

  • PPD Development (Prot #GS-US-292-0104 // Prot #GS-US-292-0104)
  • Gilead Sciences, Inc (Prot #GS-US-292-0104 // Prot #GS-US-292-0104)